Mutations in CLU lead to lower white matter and increases AD risk (Braskie et al., 2011; Masters et al., 2015) and TREM2 was identified by a genome-wide association study (GWAS) as a disease variant and risk factor for AD (Masters et al., 2015). Here, CLU is linked to Alzheimer disease.